Drug intelligence / Profile preview

Chondractiv Move

Development stage
Unknown
Lead developer
Symrise
Modality
Peptides
Administration
Oral
01

Overview

Chondractiv Move is a dietary supplement formulation developed by Givaudan (formerly Naturex) specifically designed to address activity-related joint discomfort and support cartilage health. The product is a combination of rosehip extract and Chondractiv, a proprietary hydrolyzed chicken cartilage ingredient. Chondractiv provides a natural matrix of type II collagen, chondroitin sulfate, and hyaluronic acid, which are essential structural components of joint tissue. The supplement aims to maintain the balance between cartilage synthesis and degradation, particularly in healthy individuals experiencing functional joint stress or knee pain (gonalgia) following physical activity. By combining the structural support of collagen derivatives with the anti-inflammatory properties of rosehip, Chondractiv Move is intended to improve mobility and flexibility while reducing recovery time after exercise.

Brand names
Chondractiv MoveChondractiv Boost
Other names
Rosehip extract + hydrolyzed chicken cartilage
02

Targets

COL2 (Type II Collagen)

Beyond the preview

Go deeper on Chondractiv Move.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chondractiv Move.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call